Proxies and Information Circulars

Forms of Proxy, Notices and Management Information Circulars (MIC)

Download from the corporate archives (PDF).

View the complete Arch Biopartners filings archives at the SEDAR+ website here.

2024-02-12 Notice of Meeting and Management Information Circular

2024 Notice-and-Access

2024-02-12 Form of Proxy

2024-02-12 Voter Information Form

2023-02-15 Notice of Meeting and Management Information Circular

2023-02-13 AB Beneficial Notice

2023-02-13 Form of Proxy

2023-02-13 Voter Information Form

2022-02-11 Notice of Meeting and Management Information Circular

2022-02-11 AB Beneficial Notice

2022-02-11 Form of Proxy

2022-02-11 Voter Information Form

2021-02-08 Notice of Meeting and MIC

2021-02-12 ABI Notice and Access

2021-02-12 Form of Proxy

2021-02-12 Voter Information Form

2020-02-07 Notice of Meeting and MIC

2020-02-13 Notice and Access

2020-02-13 Form of Proxy

2020-02-13 Voter Instruction Form

2019-02-08 Form of Proxy

2019-02-08 Notice of Meeting and MIC

2019-02-27 Confirmation of Mailing

2018-02-28 Form of Proxy

2018-02-28-Voter Instruction Form

2018-03-01-Notice of Meeting and MIC

2017-02-21 Form of Proxy

2017-02-21 MIC

2017-02-21 Voter Instruction Form

2017-03-01 Notice of Meeting

2016-02-01 Notice of Record and Meeting Dates

2016-02-26 Form of Proxy

2016-03-03 Notice of Meeting and MIC

2015-02-27 Form of Proxy

2015-02-27 MIC

2015-03-02 Notice of Meeting

2014-02-27 MIC

2013-02-27 MIC

2012-02-28 MIC

Download from the corporate archives (PDF).

2024 Form of Proxy, Notices and MIC

2023 Form of Proxy, Notices and MIC

2022 Form of Proxy, Notices and MIC

2021 Form of Proxy, Notices and MIC

2020 Form of Proxy, Notices and MIC

2019 Form of Proxy, Notices and MIC

2018 Form of Proxy, Notices and MIC

2017 Form of Proxy, Notices and MIC

2016 Form of Proxy, Notices and MIC

2015 Form of Proxy, Notices and MIC

2014 Form of Proxy, Notices and MIC

2013 Form of Proxy, Notices and MIC

2012 Form of Proxy, Notices and MIC

Arch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

Arch Biopartners Arranges Non-Brokered Private Placement

Closes Units for Debt Settlement

Contact Arch Biopartners

Quick Links

Legal

Connect

Mailing Address